Open Access

Diabetes mellitus type 2 does not influence carotid stiffness in patients on maintenance hemodialysis


Cite

Basic demographic, clinical, hemodialysis, and laboratory data in the diabetic and non-diabetic groups.

Diabetic N=37 median (IQR) Non diabetic N=53 median (IQR) p
Age [years] 67 [59-76] 62 [46-76] 0.13
Male gender, n (%) 15 [40.55] 28 [52.83] 0.25
Female gender, n (%) 22 [59.45] 25 [47.17] 0.25
Weight before hemodialysis [kg] 74.4 [61.2-91.3] 67.7 [60.9-80.3] 0.40
Body mass index [kg/m2] 27.3 [22.5-30.8] 24.6 [23.0-27.6] 0.06
Left ventricular ejection fraction [%] 60 [50-65] 60 [50-60] 0.94
Duration of HD therapy [months] 31.0 [10-58.5] 33.8 [9.5-95.0] 0.68
Ultrafiltration [L] 1.9 [1.3-2.5] 1.8 [1.0-2.0] 0.20
Adequacy of hemodialysis [kT/V] 1.28 [1.11-1.50] 1.40 [1.10-1.65] 0.22
SBP before HD [mmHg] 145 [120-150] 145 [130-160] 0.43
SBP after HD [mmHg] 140 [125-160] 130 [120-158] 0.56
DBP before HD [mmHg] 70 [60-80] 80 [70-90] 0.019
DBP after HD [mmHg] 73 [65-80] 80 [70-89.5] 0.27
HR before HD [mmHg] 75 [61-86] 72 [67-79] 0.72
HR after HD [mmHg] 72.5 [63-83] 80 [65-84] 0.55
Urea before HD [mg/dl] 114 [92-132] 117 [99-137] 0.65
Urea after HD [mg/dl] 36 [27-47] 35 [26-46] 0.68
Creatinine before HD [mg/dl] 6.46 [3.35-7.95] 8.04 [5.57-9.65] 0.038
Creatinine after HD [mg/dl] 2.73 [1.99-3.81] 2.73 [2.15-4.26] 0.44
Hemoglobin [g/dl] 10.8 [9.4-11.4] 10.4 [9.5-12.1] 0.95
Total cholesterol [mg/dl] 167 [142-209] 171 [146-209] 0.76
High-density lipoprotein [mg/dl] 40 [34-46] 42 [36-48] 0.58
Low-density lipoprotein [mg/dl] 92 [69-129] 95 [76-120] 0.83
Triglycerides [mg/dl] 165 [119-263] 146 [95-221] 0.13
C-reactive protein [mg/l] 5.63 [3.03-23.07] 8.48 [3.2-19.5] 0.69
Glucose [mg/dl] 153 [118-203] 98 [90-112] < 0.001

Chronic kidney disease etiology

Diabetic N=37 n (%) Nondiabetic N=53 n (%) P
Hypertensive nephropathy 22 (59.5) 11 (20.8) <0.001
Diabetic nephropathy 8 (21.6) 0 (0) <0.001
Chronic glomerular disease 3 (8.1) 21 (39.6) <0.001
Polycystic kidney disease 1 (2.7) 7 (13.2) 0.18
Interstitial nephropathy 2 (5.4) 8 (15.1) 0.12
Other 1 (2.7) 7 (13.2) 0.08

Cardiovascular co-morbidity

Diabetic N=37 n (%) Non-diabetic N=53 n (%) P
Arterial hypertension 31 (83.8) 38 (71.7) 0.18
Myocardial infarction 8 (21.6) 7 (13.2) 0.29
Coronary artery disease 21 (56.8) 17 (32.1) 0.02
Coronary artery bypass graft 6 (16.2) 1 (1.9) 0.01
Percutaneous cardiac intervention 9 (24.3) 7 (13.2) 0.17
Stroke 8 (21.6) 4 (7.6) 0.053

Cardiovascular and non-cardiovascular mortality – comparison in both groups

Survived N=47 pts Cardiovascular death N=19 pts Non-cardiovascular death N=24 pts
Non-diabetic patients N=53 74.47% (35) 52.63% (10) 33.33% (8)
Diabetic patients N=37 25.53% (12) 47.37% (9) 66.67% * (16)

Carotid stiffness parameters assessed by means of echo tracking between diabetic and non-diabetic patients

Diabetic N=37 median (IQR) Non-diabetic N=53 median (IQR) p
β before HD 7.65 [5.35–10.55] 7.85 [4.7–10.8] 0.91
β after HD 7.7 [5.3–9.0] 7.1 [5.35–8.65] 0.53
PWV β before HD [m/s] 5.95 [4.55–7.15] 5.9 [4.8–7.3] 0.77
PWV β after HD [m/s] 5.8 [4.7–6.5] 5.8 [5.100–6.425] 0.92
AC before HD [mm2/kPa] 0.71 [0.56–1.24] 0.795 [0.530–1.020] 0.49
AC after HD [mm2/kPa] 0.87 [0.68–1.04] 0.765 [0.570–1.000] 0.29
Ep before HD [kPa] 103 [67–146] 116 [69–155] 0.76
Ep after HD [kPa] 99 [68–139] 95 [72–119] 0.64
eISSN:
1732-2693
Language:
English